Scientists use living host cells as production centers to make drug products, such as biologics and therapeutic recombinant proteins. However, cells introduce a source of variability and a unique set of technical challenges to biopharmaceutical production. Researchers need early awareness of the obstacles that may interfere with an efficient development process to make informed project decisions.
Download this white paper from Sartorius to discover solutions to misinformed decision-making when developing robust, reliable, and high-yielding cell lines.
